BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Approval

Biogen Inc. Secures Global Rights To Felzartamab Through Greater China Deal With TJ Biopharma

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one...

April 22, 2026 | News

Mabwell Secures JFDA GMP Compliance For Denosumab Biosimilars, Marking PIC S Milestone

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-m...

April 22, 2026 | News

Orthogon Therapeutics Secures 11 Million Dollars To Advance First In Class Oral Therapy For BK Virus In Transplant Patients

Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...

April 21, 2026 | News

EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study

First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...

April 21, 2026 | News

Lynk Pharmaceuticals Secures China NDA Acceptance For Zemprocitinib In Atopic Dermatitis

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammat...

April 13, 2026 | News

Ascletis Pharma Inc. Advances Oral GLP 1 And Amylin Combination For Obesity Treatment

-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in...

April 09, 2026 | News

Toshiba Corporation Advances Quantum Inspired Computing With 100 Fold Faster Optimisation Algorithm

Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprie...

April 08, 2026 | News

Perceptive Discovery Expands In Vitro Capabilities To Accelerate Oncology Drug Development

Perceptive Discovery, a leading scientific partner to the global biopharmaceutical industry, announced a major expansion of its in vitro laboratory capabil...

April 07, 2026 | News

Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer

- Collaboration with Amgen to explore the clinical potential of Zai Lab’s DLL3-targeting ADC, zocilurtatug pelitecan, in combination with Amge...

April 03, 2026 | News

Abbisko Therapeutics Secures EMA Orphan Drug Status For Irpagratinib In Liver Cancer

Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256) announced that its independently developed, highly selective, oral...

April 02, 2026 | News

Abbisko Therapeutics Secures FDA IND Clearance For ABSK061 In Achondroplasia

Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced that the U.S. Food and Drug Administration has cleare...

April 01, 2026 | News

Centivax Secures 37 Million Dollars In Oversubscribed Financing To Advance Universal Influenza Vaccine

Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets,...

April 01, 2026 | News

Biogen Secures Exclusive Rights To Develop Subcutaneous Biologics Using Alteogen’s ALT B4 Platform

Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 Alteogen Inc. (KOSDAQ: 196170) ann...

March 27, 2026 | News

Everest Medicines Acquires CARDAMYST Rights To Strengthen Cardiovascular Portfolio In Greater China

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

March 24, 2026 | News

Stay Connected